ARKK’s 0.75% Fee Quietly Costs You $55 a Year on Every $10,000 Invested

If you own ARK Innovation ETF (NYSEARCA:ARKK), you are paying a premium price for a fund that has, over the past five years, gone the wrong way. The sticker fee is just the start. The deeper cost is what the marketing copy never quantifies for you: a five-year hole next to the index it asks you to bet against.

What You Are Actually Paying

ARKK’s stated annual expense ratio is 0.75%. On a $10,000 position, that quietly skims $75 a year off the top. Compare that to a plain Nasdaq 100 tracker like Invesco QQQ Trust (NASDAQ:QQQ), which charges roughly 0.20%, or about $20 a year on the same $10,000. The gap is $55 a year, every year, before any market move.

Stretch that gap. Held for 20 years, paying an extra $55 annually on $10,000 compounds against you as the balance grows. On a $100,000 position, the fee differential alone runs in the four figures per year. That money never shows up on a brokerage statement as a line item. It is taken inside the fund, off the NAV, before you ever see a return.

The Part the Factsheet Does Not Highlight

The bigger issue is performance net of that fee. Over the past five years, ARKK has returned -33.06%, with the share price falling from $117.26 on June 18, 2021 to $78.49 on June 17, 2026. Over the same window, QQQ returned +110.87%. One source put it plainly: “Over five years, the ARK Innovation ETF (ARKK) has shown a 33% loss with high volatility, while the VanEck Morningstar Wide Moat ETF (MOAT) gained 45% with steadier returns.”

Concentration is the second hidden cost. ARKK runs 46 to 48 equities, with Tesla at 10.46% of the portfolio and AMD at 5.66% as of May 2026. One bad call on Tesla rewrites your year. Active reshuffling adds a third cost: trading inside the fund. Recent moves include a $529.7 million SpaceX purchase on June 15, a $16.2 million Tesla sale on June 13, and roughly $99 million of Alphabet bought on June 7. High turnover can trigger short-term capital gains distributions that the holder pays tax on, even in a down year. One analysis flagged the structural issue directly: “Investors must weigh its potential against its history of severe drawdowns and high expense ratio, understanding that its active management prioritizes thematic persistence over tactical flexibility.”

The Cheaper Mirror

If the appeal is large-cap U.S. innovation exposure, QQQ delivers it at a fraction of the cost, with a one-year return of 36.56% versus ARKK’s 22.81% through June 17, 2026. The trade-off is real: QQQ tilts heavily to mega-cap profitable tech and skips the unprofitable disruptors Cathie Wood favors. For broader, lower-volatility quality, MOAT is the comparison sources keep returning to, with that +45% five-year return. Neither holds Coinbase or CRISPR Therapeutics in size, so you give up the lottery ticket on gene editing and crypto infrastructure.

What This Means for You

Reddit’s r/wallstreetbets has been blunter than the factsheets. The most-upvoted ARKK thread in late May was titled “I bought terrible meme stuff like ARKK as it all tanked to the lows, then diversified.” Another widely read post on r/investing asked, “How does anyone take Cathie Wood seriously?” The crowd is paying attention to the gap between the pitch and the result.

ARKK already rebounded in 2025, returning 35.49%. The question worth asking is whether you are paying 0.75% a year, plus turnover, plus concentration risk, for an exposure you could approximate at a quarter of the cost. If the answer is no, the “hidden” cost is not hidden anymore.